Stemsation International Inc STSN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.05
- Day Range
- $0.04–0.04
- 52-Week Range
- $0.00–0.07
- Bid/Ask
- $0.03 / $0.06
- Market Cap
- $10.81 Mil
- Volume/Avg
- 90,050 / 64,116
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Stemsation International Inc is engaged in the marketing and direct selling of natural wellness products and nutritional supplements. The company uses a direct selling business model to distribute and market its products. Its product includes StemRCM; ProStem PSP and StemFlex.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 4
- Website
- https://www.stemsation.global
Valuation
|
Metric
|
STSN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
STSN
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.01 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
STSN
|
|---|---|
Return on Assets (Normalized) | −97.51% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −135.60% |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Qwmjyzvcp | Gxbf | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Dkhkfwwm | Jwgnjy | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Xmbtqfzp | Tlfmb | $41.4 Bil | |||
| Viatris Inc
VTRS
| Lfdfsndw | Byp | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Mqbgsbw | Hkcc | $13.7 Bil | |||
| Catalent Inc
CTLT
| Cgfxxtxr | Dsvsqcp | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Vmrydxbdp | Vscnt | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Bpqhgfvm | Btmbmx | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Lbdwvxhx | Sqvbb | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Snscsgyds | Qrhzl | $2.7 Bil |